BD ChloraPrep™ Clear - 1mL Applicator: Product sterility
Product sterility could be compromised in affected lots.
Publisher
Canada
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Health Canada Recalls and Safety Alerts
- Region
- Canada
- Scope
- Regulatory
- Published
- July 13, 2026
- Language
- EN
Topics
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Product sterility could be compromised in affected lots.
Source route
Continue on recalls-rappels.canada.ca
Leave the platform to read the original full article on the publisher site.
Source: Health Canada Recalls and Safety Alerts
Scope: Regulatory
Related coverage
More related coverage
Review Body on Doctors' and Dentists' Remuneration remit letter: 2027 to 2028
Letter about the pay round for the financial year 2027 to 2028 from the Secretary of State for Healt...
NHS Pay Review Body remit letter: 2027 to 2028
Letter about the pay round for the financial year 2027 to 2028 from the Secretary of State for Healt...
Senior Salaries Review Body remit letter: 2027 to 2028
Letter about the pay round for the financial year 2027 to 2028 from the Secretary of State for Healt...
Surveillance of bloodstream infections in intensive care units, England: 2025
Annual report and data tables showing how often bloodstream infections occur in critical care in Eng...